The Director of Health Economics and Outcomes Research (HEOR) will lead the development and execution of HEOR strategies for CSL Behring or Vifor assets, primarily within a specific disease area. This role focuses on leading the plan, execution, and dissemination of payer evidence generation to maximize the asset's value throughout its life cycle by securing and optimizing product pricing and reimbursement.
This position requires deep expertise in Health Economics, Real-World Evidence (RWE), and Health Technology Assessment (HTA) with a hands-on approach to executing HTA submissions and RWE studies.
You will be directly reporting to the Executive Director HEOR, Market Access.
Potential locations: Switzerland (Zurich) or USA (King of Prussia).
Key Responsibilities
* Lead development, oversight, and execution of comprehensive and effective HEOR strategies demonstrating the value of CSL's products to enable fast and optimal access worldwide.
* Plan, execute, and disseminate global value evidence generation studies and tools, such as Burden of Illness studies, Patient Preference and Patient Report Outcomes studies, Systematic Literature Reviews, Indirect Treatment Comparisons, Global Value Dossier, economic models, practical HEOR tools for payer engagement, etc.
* Engage with the Access Leads and Product Strategy Teams to facilitate early and appropriate evidence generation in pivotal trials, identify gaps, and shape mitigation strategies for worldwide HTA's.
* Support Access leads in planning and conducting Early Scientific Advice with key P&R and HTA agencies.
* Shape pivotal trial design to adequately reflect payer evidence requirements, especially PICO (population, intervention, comparator, outcomes), devise mitigation strategies early on.
* Collaborate with Medical Affairs, Epidemiology, Biostatistics, and other relevant functions to develop and execute integrated evidence generation plans, driving value evidence needs definition, execution, and compliant dissemination/communication based on the strategic objectives of the brand plan.
* Lead cross-functional teams to prepare EU JCA dossier and JSC/payer consultations, ensuring cross-functional alignment and seamless execution.
* Support and ensure governance of local HTA submissions, adapting global HEOR value dossiers, health economic models, and tools and anticipating evidence needs.
* Ensure HEOR initiatives are aligned with business needs and adequately funded.
* Foster collaboration with KOLs and internal and external partners to introduce innovative approaches and methods and validate the HEOR strategy.
* Support shaping and sharing of internal processes, procedures, approaches, and best practices to elevate HEOR effectiveness.
* Educate stakeholders on HTA and value evidence key requirements and developments.
Qualifications
* Experience: At least 10 years of experience in HEOR/market access, with significant exposure to healthcare systems in international markets.
* Excellent analytical skills with experience in statistical modeling, data analysis, and interpretation of research findings.
* Track Record: Demonstrated success in developing and executing HEOR and HTA strategies to secure and optimize pricing, reimbursement, and patient access.
* Knowledge: Extensive understanding of HTA and benefit assessment processes and dynamics in key international markets.
* Collaboration: Proven ability to work effectively in cross-functional teams, with strong communication and influencing skills.
* Education: An advanced degree in Health Economics, Public Health, or a related field is required.